Venetoclax combinations induce high response rates in newly diagnosed acute myeloid leukemia patients ineligible for intensive chemotherapy in routine practice
暂无分享,去创建一个
A. Gural | Y. Ofran | J. Canaani | O. Wolach | May Basood | M. Zektser | A. Duek | C. Ganzel | M. Koren-Michowitz | A. Apel | G. Stemer | I. Hellman | A. Frisch | C. Leibovitch | Y. Moshe | M. Basood